| UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668) | Masonic Cancer Center, University of Minnesota | 2017-05-15 |
| Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders (NCT03128996) | Washington University School of Medicine | 2017-03-20 |
| Investigation of the Genetics of Hematologic Diseases (NCT02720679) | St. Jude Children's Research Hospital | 2016-06-17 |
| Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases (NCT02349906) | medac GmbH | 2015-04-01 |
| Fludarabine Based RIC for Bone Marrow Failure Syndromes (NCT02928991) | Children's Hospital of Philadelphia | 2015-04-01 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation (NCT02337595) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2014-08-01 |
| Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia (NCT02224872) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-01 |
| Nandrolone Decanoate in the Treatment of Telomeropathies (NCT02055456) | University of Sao Paulo | 2014-02-01 |
| Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC (NCT02356653) | Children's Hospital of Philadelphia | 2013-12-01 |
| Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases (NCT02277639) | Children's Hospital of Philadelphia | 2011-11-01 |
| Identifying Characteristics of Bone Marrow Failure Syndromes (NCT00315419) | Office of Rare Diseases (ORD) | 2006-04-01 |
| Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT (NCT00774527) | Cooperative Study Group A for Hematology | 2003-03-01 |
| Unrelated Donor Transplant for Malignant and Non-Malignant Disorders (NCT01050439) | Columbia University | 2002-11-01 |